Mette Levinsen

557 total citations
17 papers, 218 citations indexed

About

Mette Levinsen is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Mette Levinsen has authored 17 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 11 papers in Pediatrics, Perinatology and Child Health and 5 papers in Genetics. Recurrent topics in Mette Levinsen's work include Acute Lymphoblastic Leukemia research (13 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Glioma Diagnosis and Treatment (5 papers). Mette Levinsen is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Glioma Diagnosis and Treatment (5 papers). Mette Levinsen collaborates with scholars based in Denmark, Finland and Sweden. Mette Levinsen's co-authors include Kjeld Schmiegelow, Mervi Taskinen, Arja Harila‐Saari, Jonas Abrahamsson, Mats Heyman, Susanne Rosthøj, Thomas Leth Frandsen, Maarit Palomäki, Riitta Niinimäki and Susanna Ranta and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Mette Levinsen

16 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mette Levinsen Denmark 10 138 104 70 47 32 17 218
Teresa Olivé Spain 9 89 0.6× 86 0.8× 75 1.1× 56 1.2× 40 1.3× 16 301
Olga Zając‐Spychała Poland 11 87 0.6× 76 0.7× 57 0.8× 24 0.5× 93 2.9× 35 273
Lisa Murray United States 7 45 0.3× 58 0.6× 96 1.4× 76 1.6× 19 0.6× 12 195
Marina Kunstreich Germany 9 94 0.7× 53 0.5× 52 0.7× 21 0.4× 48 1.5× 31 232
Anna Pieczonka Poland 9 60 0.4× 45 0.4× 107 1.5× 15 0.3× 45 1.4× 31 202
Nadira Azzi Belgium 8 30 0.2× 80 0.8× 91 1.3× 137 2.9× 30 0.9× 12 249
H. Langermann Germany 8 218 1.6× 126 1.2× 121 1.7× 58 1.2× 47 1.5× 15 286
Maja Bulatović Ćalasan Netherlands 11 167 1.2× 41 0.4× 243 3.5× 75 1.6× 21 0.7× 18 424
Nora Mühlegger Austria 8 289 2.1× 113 1.1× 267 3.8× 30 0.6× 52 1.6× 11 372
Hesham Eissa United States 5 54 0.4× 55 0.5× 105 1.5× 63 1.3× 25 0.8× 14 177

Countries citing papers authored by Mette Levinsen

Since Specialization
Citations

This map shows the geographic impact of Mette Levinsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette Levinsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette Levinsen more than expected).

Fields of papers citing papers by Mette Levinsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mette Levinsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette Levinsen. The network helps show where Mette Levinsen may publish in the future.

Co-authorship network of co-authors of Mette Levinsen

This figure shows the co-authorship network connecting the top 25 collaborators of Mette Levinsen. A scholar is included among the top collaborators of Mette Levinsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mette Levinsen. Mette Levinsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Levinsen, Mette, Malene Landbo Børresen, Laura Roos, Karen Grønskov, & Line Kessel. (2021). Causes of poor eye contact in infants: a population-based study. BMC Ophthalmology. 21(1). 388–388. 3 indexed citations
3.
Levinsen, Mette, et al.. (2021). Medical and surgical treatment of rhino-orbital-cerebral mucormycosis in a child with leukemia. American Journal of Ophthalmology Case Reports. 22. 101092–101092. 7 indexed citations
4.
Thastrup, Ole, Hanne Vibeke Marquart, Mette Levinsen, et al.. (2021). Flow cytometric analysis of cerebrospinal fluid improves detection of leukaemic blasts in infants with acute lymphoblastic leukaemia. British Journal of Haematology. 195(1). 119–122. 6 indexed citations
5.
Modvig, Signe, Ole Thastrup, Mette Levinsen, et al.. (2019). A Comprehensive Study of Human Integrins in Pediatric Lymphoblastic Leukemia Supports a Role of CD49f (Integrin α6) in the Localization to Bone Marrow but Not Spinal Fluid. Blood. 134(Supplement_1). 5205–5205. 1 indexed citations
6.
Thastrup, Ole, Hanne Vibeke Marquart, Mette Levinsen, et al.. (2018). Central Nervous System Involvement Detected By Flow Cytometry Is a Risk Factor for Relapse in Childhood Acute Lymphoblastic Leukemia. Blood. 132(Supplement 1). 657–657. 2 indexed citations
7.
Ranta, Susanna, Maarit Palomäki, Mette Levinsen, et al.. (2017). Presenting features and imaging in childhood acute myeloid leukemia with central nervous system involvement. Pediatric Blood & Cancer. 64(12). 16 indexed citations
8.
Levinsen, Mette, Hanne Vibeke Marquart, Line Groth‐Pedersen, et al.. (2016). Leukemic blasts are present at low levels in spinal fluid in one‐third of childhood acute lymphoblastic leukemia cases. Pediatric Blood & Cancer. 63(11). 1935–1942. 29 indexed citations
9.
Taskinen, Mervi, Mette Levinsen, Matteo Bottai, et al.. (2016). The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols. Pediatric Blood & Cancer. 64(2). 242–249. 9 indexed citations
10.
Levinsen, Mette, Arja Harila‐Saari, Kathrine Grell, et al.. (2016). Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 38(8). 602–609. 16 indexed citations
11.
Ranta, Susanna, Maarit Palomäki, Mette Levinsen, et al.. (2016). Role of neuroimaging in children with acute lymphoblastic leukemia and central nervous system involvement at diagnosis. Pediatric Blood & Cancer. 64(1). 64–70. 23 indexed citations
12.
Levinsen, Mette, Susanne Rosthøj, Ulrikka Nygaard, et al.. (2014). Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity. Cancer Chemotherapy and Pharmacology. 75(1). 59–66. 16 indexed citations
13.
Levinsen, Mette, Mervi Taskinen, Jonas Abrahamsson, et al.. (2014). Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 61(8). 1416–1421. 20 indexed citations
14.
Levinsen, Mette, Susanne Rosthøj, Jacob Nersting, et al.. (2014). Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer. Pediatric Blood & Cancer. 61(5). 797–802. 23 indexed citations
15.
Levinsen, Mette, Susanne Rosthøj, Bernward Zeller, et al.. (2012). Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia. Leukemia. 27(4). 866–870. 26 indexed citations
16.
Levinsen, Mette, Susanne Rosthøj, Bernward Zeller, et al.. (2012). Physicians Compliance During Maintenance Therapy in Children with Down Syndrome and Acute Lymphoblastic Leukemia.. Blood. 120(21). 2577–2577. 3 indexed citations
17.
Levinsen, Mette, Arja Harila‐Saari, Ólafur G. Jónsson, et al.. (2011). Pneumocystis jirovecipneumonia prophylaxis during maintenance therapy influences methotrexate/6‐mercaptopurine dosing but not event‐free survival for childhood acute lymphoblastic leukemia. European Journal Of Haematology. 88(1). 78–86. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teresa Olivé Breakdown of academic impact, for papers by Olga Zając‐Spychała Breakdown of academic impact, for papers by Lisa Murray Breakdown of academic impact, for papers by Marina Kunstreich Breakdown of academic impact, for papers by Anna Pieczonka Breakdown of academic impact, for papers by Nadira Azzi Breakdown of academic impact, for papers by H. Langermann Breakdown of academic impact, for papers by Maja Bulatović Ćalasan Breakdown of academic impact, for papers by Nora Mühlegger Breakdown of academic impact, for papers by Hesham Eissa
Rankless by CCL
2026